ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Angiogenesis >FLT3 inhibitors >ENMD-2076 (Tartrate)

ENMD-2076 (Tartrate)

ENMD-2076 (Tartrate) Suppliers list
Company Name: Capot Chemical Co.,Ltd.
Tel: 571-85586718 +8613336195806
Email: sales@capotchem.com
Products Intro: Product Name:ENMD-2076
CAS:1291074-87-7
Purity:98%(Min,HPLC) Package:100g;1kg;5kg,10kg,25kg,50kg
Company Name: Hubei Jusheng Technology Co.,Ltd.
Tel: 18871490254
Email: linda@hubeijusheng.com
Products Intro: Product Name:ENMD-2076 (Tartrate)
CAS:1291074-87-7
Purity:0.99 Package:5KG;1KG
Company Name: Career Henan Chemica Co
Tel: +86-0371-86658258 15093356674;
Email: laboratory@coreychem.com
Products Intro: Product Name:ENMD-2076 (Tartrate)
CAS:1291074-87-7
Purity:95% Package:1g;6USD
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Products Intro: Product Name:ENMD-2076 tartrate
CAS:1291074-87-7
Purity:82999% Package:10kg 25kg 200 kilograms per barrel Remarks:good
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:ENMD-2076 Tartrate
CAS:1291074-87-7
Purity:98% Package:5mg Remarks:V0528
ENMD-2076 (Tartrate) Basic information
Product Name:ENMD-2076 (Tartrate)
Synonyms:(E)-N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine,L-(+)-Tartaric acid;ENMD-2076 (Tartrate);ENMD-2076 L-(+)-Tartaric acid;ENMD-2076 tartrate (ENMD 2076
CAS:1291074-87-7
MF:C21H25N7.x(C4H6O6)
MW:0
EINECS:
Product Categories:Inhibitors;Inhibitor
Mol File:Mol File
ENMD-2076 (Tartrate) Structure
ENMD-2076 (Tartrate) Chemical Properties
storage temp. Store at -20°C
solubility insoluble in EtOH; ≥175.8 mg/mL in DMSO
form solid
Safety Information
MSDS Information
ENMD-2076 (Tartrate) Usage And Synthesis
UsesENMD-2076 (ENMD-981693, ENMD2076) is a antiangiogenic and Aurora kinase inhibitor with IC50 of 3, 13, 350, 23, 40, 93 and 120 nM for Flt-3, AurA, AurB, Src, KDR/VEGFR2 and FGFR1.
Biological Activityenmd-2076 is an orally bioavailable, small molecule inhibitor of aurora kinases with ic50 values of 14nm and 350nm, respectively against aurora kinase a and aurora kinase b [1].besides aurora kinases, enmd-2076 inhibits multiple kinases involved in various cellular activities. overexpression of aurora kinase a has been found in breast cancers and enmd-2076 is thereby studied in breast cancers. it is reported that enmd-2076 differentially inhibits 29 breast cancer cell lines with ic50 values ranged from 0.25 to 16.1μm. in the clonogenic assays, enmd-2076 totally suppresses the colony formation in the sensitivemda-mb-468 cell line and decreases the formation in thehcc1806, sk-br-3, and bt474 cell lines. enmd-2076 is also reported to cause a g2 cell-cycle arrest at 1.25μm. moreover, enmd-2076 shows antitumor activity in tnbc xenograft models. apart from the breast cancers, enmd-2076 is developed in hematological malignancies therapy. the
references[1] diamond jr, eckhardt sg, tan ac, newton tp, selby hm, brunkow kl, kachaeva mi, varella-garcia m, pitts tm, bray mr, fletcher gc, tentler jj. predictive biomarkers of sensitivity to the aurora and angiogenic kinase inhibitor enmd-2076 in preclinical breast cancer models. clin cancer res. 2013 jan 1;19(1):291-303.
[2] how j, yee k. enmd-2076 for hematological malignancies. expert opin investig drugs. 2012 may;21(5):717-32.
ENMD-2076 (Tartrate) Preparation Products And Raw materials
Tag:ENMD-2076 (Tartrate)(1291074-87-7) Related Product Information
Alisertib (MLN8237)